The autologous CAR T cell therapy market pertains to the demand for CAR T cell therapies derived from a patient’s cells. CAR T cell therapy is a form of immunotherapy that involves modifying a patient's T cells to identify and attack cancer cells. This is achieved by engineering the T cells with a chimeric antigen receptor (CAR) that recognizes specific cancer cells.
read more..